Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
about
Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal DetectionStandardizing adverse drug event reporting dataTrends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry dataData mining of the public version of the FDA Adverse Event Reporting SystemTriptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System.Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase(®).Exploitation of semantic methods to cluster pharmacovigilance termsProton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System.Towards a framework for developing semantic relatedness reference standards.Using information mining of the medical literature to improve drug safety.U-path: An undirected path-based measure of semantic similarity.Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications.Evaluation of automated term groupings for detecting anaphylactic shock signals for drugs.The contribution of the vaccine adverse event text mining system to the classification of possible Guillain-Barré syndrome reports.Good Signal Detection Practices: Evidence from IMI PROTECTThe Use of the Medical Dictionary for Regulatory Activities in the Identification of Mitochondrial Dysfunction in HIV-Infected Children.Gastrointestinal disorders and dabigatran.MedDRA® automated term groupings using OntoADR: evaluation with upper gastrointestinal bleedings.Evaluating semantic relatedness and similarity measures with Standardized MedDRA QueriesDronedarone and renal impairment: evaluation of Spanish postmarketing reports and review of literature.Discovering adverse drug events combining spontaneous reports with electronic medical records: a case study of conventional DMARDs and biologics for rheumatoid arthritis.Seasonal and Geographic Variation in Adverse Event Reporting.Detection of dechallenge in spontaneous reporting systems: a comparison of Bayes methods.Performance of the standardised MedDRA® queries for case retrieval in the French spontaneous reporting database.Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases.A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France.Terminological challenges in safety surveillance.Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.
P2860
Q27335410-24427639-7216-4ED7-A05C-40C93FFA4B82Q28654311-3FE061F4-2450-4631-B9C4-C9D9921096C8Q30629456-75D89ADC-461E-48CE-B88B-8214B24F8095Q30651235-DAC51701-15EE-413A-96CE-0CDDFF07BC04Q30660036-91998390-57CB-48A7-BACC-F3E21E9B8FF8Q30884142-BBB0015B-2453-472E-855E-CB03F58113C6Q31056264-7E98E6DE-16CE-4C16-B373-B566E42EFED6Q33715057-62275AB1-6DA4-4442-B2B1-41C39F84FBBDQ33912042-B12FC577-FE89-46A4-9D37-48EBDC190E96Q34713606-61AED074-F590-4DC6-88A1-8040D3255676Q35200247-6BAB0612-90DE-440D-ABBB-0CBB0DABC584Q35570423-E394B90A-7C32-4BFA-8349-2C908F970902Q36389336-83CDA37A-C39C-407E-893F-BC0EC52A6A64Q36519210-3F1A8DB5-25C0-4BF7-9E61-2690D07A97F6Q36817854-55B85CD0-85D9-4018-B8BF-BF8F62B13847Q36914069-97178CA6-4A8B-4F0D-95D5-5A0016BE3327Q36929688-F581001A-7DA3-426F-B3E2-90569E6BCD80Q38041636-55781943-76AA-45E6-8EA2-34E2F857153DQ38390830-DD67D896-0173-42FD-8C4C-213A24272CC6Q38458036-50CB6E21-9F01-499C-9B24-C9393001EBB0Q38476023-C2334FDA-A280-4FD3-8F1F-4EE9F2585FF6Q38621179-9A577AF8-97D9-4962-BC8A-F79727430555Q39284254-D836356E-C89A-4053-B47E-63D25D9F5D0FQ41228938-0B776B8F-F951-4296-9F15-C6523DC4B234Q43708146-99C57713-50AA-47F0-B9A6-986EDDE105DBQ44428648-76AAF839-1862-4D2F-9BE1-10DD804CF13DQ46200243-FAE050B0-D6E6-41B0-9B8A-9ED78413A257Q51483617-4FBF3590-F36F-4BC0-B46C-05BA61256BEDQ53105748-822ACC7E-1D3D-499D-B54F-7F0516E6B897
P2860
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
@ast
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
@en
type
label
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
@ast
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
@en
prefLabel
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
@ast
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
@en
P2093
P1476
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
@en
P2093
A Lawrence Gould
Alan M Hochberg
David I Goldsmith
David Madigan
Donald J O'Hara
Manfred Hauben
Ronald K Pearson
Stephanie J Reisinger
P304
P356
10.1016/J.IJMEDINF.2009.01.001
P577
2009-02-18T00:00:00Z